Xarelto is one of the newest anticoagulants in the market today. It belongs to a class of drugs known as blood thinners. These substances are designed to prevent lethal blood clots that can prevent blood from flowing to the vital organs. Manufactured by Johnson and Johnson subsidiary Janssen Pharmaceuticals, Xarelto is now regarded as one of the most lethal drugs in the market.

In 2011, the Food and Drug Administration (FDA) has approved the use of Xarelto for preventing stroke in patients who suffer from a condition called atrial fibrillation. Likewise, it is used for treating and preventing blood clots. In addition, it is also used for the prevention of blood clots in patients who have undergone hip or knee replacement surgeries. Unfortunately, the manufacturers have marketed it for other unapproved uses.

According to the website of Abel Law Firm, drugs should be tested for functionality and prospective side effects. The bad news is that manufacturers do not re-test the drugs upon submission to the FDA for approval. One of the worst side effect s of Xarelto is uncontrolled bleeding. When this happens, blood flow to organs such as the brain, lungs, or kidney can be interrupted causing them to malfunction. The effects of Xarelto should be felt within 8 to 12 hours a day but with uncontrolled bleeding, the normal clotting of the blood can be prevented. As a result, the patient could experience gastrointestinal bleeding, epidural bleeding, and stroke.

According to data compiled by heath website HealthGrove from 2004 through 2015, Xarelto was ranked 24th on the list of the top 50 most dangerous drugs. It yielded 81 percent of reactions which is considered serious. Reports by the FDA revealed that 50 percent of the adverse effects of Xarelto accounted for blood clots. For this reason, several product liability and wrongful death suits have been filed against Johnson & Johnson for their failure to inform patients of such effects.

Read More